Sahin U - Search Results

1

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.

Sahin U, Oehm P, Derhovanessian E, Jabulowsky RA, Vormehr M, Gold M, Maurus D, Schwarck-Kokarakis D, Kuhn AN, Omokoko T, Kranz LM, Diken M, Kreiter S, Haas H, Attig S, Rae R, Cuk K, Kemmer-Brück A, Breitkreuz A, Tolliver C, Caspar J, Quinkhardt J, Hebich L, Stein M, Hohberger A, Vogler I, Liebig I, Renken S, Sikorski J, Leierer M, Müller V, Mitzel-Rink H, Miederer M, Huber C, Grabbe S, Utikal J, Pinter A, Kaufmann R, Hassel JC, Loquai C, Türeci Ö. Sahin U, et al. Nature. 2020 Sep;585(7823):107-112. doi: 10.1038/s41586-020-2537-9. Epub 2020 Jul 29. Nature. 2020. PMID: 32728218 Clinical Trial.

2

Serological analysis of human tumor antigens: molecular definition and implications.

Türeci O, Sahin U, Pfreundschuh M. Türeci O, et al. Among authors: sahin u. Mol Med Today. 1997 Aug;3(8):342-9. doi: 10.1016/s1357-4310(97)01081-2. Mol Med Today. 1997. PMID: 9269687 Review.

3

Serological identification of human tumor antigens.

Sahin U, Türeci O, Pfreundschuh M. Sahin U, et al. Curr Opin Immunol. 1997 Oct;9(5):709-16. doi: 10.1016/s0952-7915(97)80053-2. Curr Opin Immunol. 1997. PMID: 9368781 Review.

4

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies.

Sahin U, Türeci O, Chen YT, Seitz G, Villena-Heinsen C, Old LJ, Pfreundschuh M. Sahin U, et al. Int J Cancer. 1998 Oct 29;78(3):387-9. doi: 10.1002/(SICI)1097-0215(19981029)78:3<387::AID-IJC22>3.0.CO;2-2. Int J Cancer. 1998. PMID: 9766577 Free article. No abstract available.

5

Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer.

Koslowski M, Türeci O, Bell C, Krause P, Lehr HA, Brunner J, Seitz G, Nestle FO, Huber C, Sahin U. Koslowski M, et al. Among authors: sahin u. Cancer Res. 2002 Nov 15;62(22):6750-5. Cancer Res. 2002. PMID: 12438276

6

SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity.

Krause P, Türeci O, Micke P, Buhl R, Huber C, Sahin U. Krause P, et al. Among authors: sahin u. J Immunol Methods. 2003 Dec;283(1-2):261-7. doi: 10.1016/j.jim.2003.09.014. J Immunol Methods. 2003. PMID: 14659917

7

CrELISA: a fast and robust enzyme-linked immunosorbent assay bypassing the need for purification of recombinant protein.

Türeci O, Luxemburger U, Heinen H, Mack U, Sybrecht GW, Huber C, Sahin U. Türeci O, et al. Among authors: sahin u. J Immunol Methods. 2004 Jun;289(1-2):191-9. doi: 10.1016/j.jim.2004.04.020. J Immunol Methods. 2004. PMID: 15251424

8

Frequent nonrandom activation of germ-line genes in human cancer.

Koslowski M, Bell C, Seitz G, Lehr HA, Roemer K, Müntefering H, Huber C, Sahin U, Türeci O. Koslowski M, et al. Among authors: sahin u. Cancer Res. 2004 Sep 1;64(17):5988-93. doi: 10.1158/0008-5472.CAN-04-1187. Cancer Res. 2004. PMID: 15342378

9

Identification of tumor-associated autoantigens with SEREX.

Türeci O, Usener D, Schneider S, Sahin U. Türeci O, et al. Among authors: sahin u. Methods Mol Med. 2005;109:137-54. doi: 10.1385/1-59259-862-5:137. Methods Mol Med. 2005. PMID: 15585919

10

Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1.

Türeci O, Mack U, Luxemburger U, Heinen H, Krummenauer F, Sester M, Sester U, Sybrecht GW, Sahin U. Türeci O, et al. Among authors: sahin u. Cancer Lett. 2006 May 8;236(1):64-71. doi: 10.1016/j.canlet.2005.05.008. Epub 2005 Jun 29. Cancer Lett. 2006. PMID: 15992994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

490 results

Search Page